ABC News' Dr. Tara Narula breaks down new findings suggesting that popular diabetes and weight loss medications may also help reduce alcohol and drug cravings.
GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...
A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without ...
People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.
Discover a study comparing tirzepatide, semaglutide, and liraglutide in MASLD, revealing significant reductions in liver ...
At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA), particularly tirzepatide (Zepbound), which late last year became the ...
In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...
This is read by an automated voice. Please report any issues or inconsistencies here. If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to ...
Hemoglobin A1c, fasting glucose, body weight, and systolic blood pressure decreased significantly in association with GLP-1 RAs. Pareeta Kotecha, Pharm.D., from the University of Florida in ...
Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an additional 2.5% total body weight after stopping GLP-1 drugs vs. 10% ...
Watch What Happens Live host Andy Cohen addressed his controversial prank with Howard Stern, his drama with the W Hotel after his recent move, and how a “terrible” Bravo reunion moment led to him ...
Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to moderate weight loss as a secondary effect due to its action as a GLP-1 ...